BPI Bundesverband der Pharmazeutischen Industrie

Berlin – November 05, 2026 -- Germany's pharmaceutical lobby BPI says the country's healthcare system is neither crisis-proof nor crisis-resilient, as external shocks collide with structural weaknesses in both the industry base and patient supply. BPI Managing Director Dr. Kai Joachimsen made the assessment at the FORUM-Institut's annual health policy conference, "Pharma Trends 2027".

Joachimsen lists five pressure points behind the "polycrisis"

He cited trade conflicts, a dependence on Asia that is still tending to grow despite repeated warnings, fragile supply chains, cyberattacks, and scarce, expensive energy and raw materials.

Joachimsen argued that policy has not matched the threat level. In his view, health policy is location policy and must now also function as security policy.

Brussels – November 04, 2026 -- The head of Germany's pharmaceutical industry association BPI has said the EU is not prepared for a health crisis, calling European and national policy inadequate for the current geopolitical tensions.

BPI Chairman Oliver Kirst made the remarks at the association's autumn reception at the Bibliothèque Solvay in Brussels. He described the lack of crisis resilience as irresponsible and said EU action is too slow and too bureaucratic.

Critical Medicines Act still awaits formal adoption

Kirst named the Critical Medicines Act (CMA) as the prime example of EU hesitation. He called its aim of returning critical medicine production to Europe right and urgent. The act, he noted, has been debated for a long time and still has to be formally adopted.

Chairman lists open questions on production, storage and protection

Kirst said too many questions remain unanswered:

Berlin – – September 16, 2026 -- The Bundesverband der Pharmazeutischen Industrie (BPI) will bring together four senior stakeholders from pharmacy, politics, health insurance and the pharmaceutical industry on September 16, 2026, to debate how prevention can be scaled across Germany's healthcare system.

BPI schedules prevention panel for expopharm networking breakfast

The discussion, titled "Prävention als Chance für unser Gesundheitssystem," takes place at 9:00 a.m. (doors open 8:30 a.m.) in Hall A3 of the pharmaworld area at expopharm, as part of the BPI's networking breakfast.

Pharmacist chamber pushes for pharmacies as broader health navigators

Franziska Scharpf, Vice President of the Bundesapothekerkammer, argues that pharmacies should expand their role as health navigators through screenings, pharmaceutical counseling, vaccination services and guided self-medication.

Berlin – – September 15, 2026 -- The European Commission today unveiled the EU Public Procurement Act (PPA), a comprehensive proposal to modernize European procurement law, drawing an immediate response from Germany's pharmaceutical industry association BPI.

BPI demands supply security as binding procurement criterion

Dr. Kai Joachimsen, Chief Executive of the BPI (Bundesverband der Pharmazeutischen Industrie), said the European Commission must make supply security a mandatory guideline for pharmaceutical procurement. He stated the goal must be supply sovereignty, achieved through strong production capacities in Europe and diversified, resilient supply chains.